
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories
Robert E. Hynds, Kristopher K. Frese, David R. Pearce, et al.
Open Biology (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 42
Robert E. Hynds, Kristopher K. Frese, David R. Pearce, et al.
Open Biology (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 42
Showing 1-25 of 42 citing articles:
Role of NRF2 in Lung Cancer
Miriam Sánchez-Ortega, Ana C. Carrera, António Garrido
Cells (2021) Vol. 10, Iss. 8, pp. 1879-1879
Open Access | Times Cited: 73
Miriam Sánchez-Ortega, Ana C. Carrera, António Garrido
Cells (2021) Vol. 10, Iss. 8, pp. 1879-1879
Open Access | Times Cited: 73
Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation
Charlotte Domblides, Juliette Rochefort, Clémence Riffard, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 59
Charlotte Domblides, Juliette Rochefort, Clémence Riffard, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 59
Vaping, Environmental Toxicants Exposure, and Lung Cancer Risk
Shaimaa A. Shehata, Eman A. Toraih, Ezzat A. Ismail, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4525-4525
Open Access | Times Cited: 28
Shaimaa A. Shehata, Eman A. Toraih, Ezzat A. Ismail, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4525-4525
Open Access | Times Cited: 28
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models
Robert E. Hynds, Ariana Huebner, David R. Pearce, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Robert E. Hynds, Ariana Huebner, David R. Pearce, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Relevance of Carcinogen-Induced Preclinical Cancer Models
Raj Nayan Sewduth, Κωνσταντίνα Γεωργέλου
Journal of Xenobiotics (2024) Vol. 14, Iss. 1, pp. 96-109
Open Access | Times Cited: 6
Raj Nayan Sewduth, Κωνσταντίνα Γεωργέλου
Journal of Xenobiotics (2024) Vol. 14, Iss. 1, pp. 96-109
Open Access | Times Cited: 6
The role of macrophages in non-small cell lung cancer and advancements in 3D co-cultures
Katarína Balážová, Hans Clevers, Antonella F. M. Dost
eLife (2023) Vol. 12
Open Access | Times Cited: 14
Katarína Balážová, Hans Clevers, Antonella F. M. Dost
eLife (2023) Vol. 12
Open Access | Times Cited: 14
Capturing heterogeneity in PDX models: representation matters
Hari Shankar Sunil, Kathryn A. O’Donnell
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Hari Shankar Sunil, Kathryn A. O’Donnell
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Online Monitoring and Stable Isotope Tracing of Cancer Associated Volatiles in Murine Model Captures Tumor Associated Markers in vivo
Fouad Choueiry, Rui Xu, Andrew Gold, et al.
Analytica Chimica Acta (2025) Vol. 1349, pp. 343826-343826
Open Access
Fouad Choueiry, Rui Xu, Andrew Gold, et al.
Analytica Chimica Acta (2025) Vol. 1349, pp. 343826-343826
Open Access
Translating premalignant biology to accelerate non-small-cell lung cancer interception
Sarah A. Mazzilli, Zahraa Rahal, Maral J. Rouhani, et al.
Nature reviews. Cancer (2025)
Closed Access
Sarah A. Mazzilli, Zahraa Rahal, Maral J. Rouhani, et al.
Nature reviews. Cancer (2025)
Closed Access
A Novel Murine Carcinogen-Induced Model Recapitulates the Progression and Heterogeneity of Human Lung Adenocarcinoma
Aparamita Pandey, Elizabeth Gomez, Ana Maria Soto, et al.
(2025)
Closed Access
Aparamita Pandey, Elizabeth Gomez, Ana Maria Soto, et al.
(2025)
Closed Access
Targeting EGFR/PI3K/AKT/mTOR and Bax/Bcl-2/caspase3 pathways with ivermectin mediates its anticancer effects against urethane-induced non-small cell lung cancer in BALB/c mice
Marina N. Malak, El‐Shaimaa A. Arafa, Maha M. Abdel‐Fattah, et al.
Tissue and Cell (2025), pp. 102873-102873
Closed Access
Marina N. Malak, El‐Shaimaa A. Arafa, Maha M. Abdel‐Fattah, et al.
Tissue and Cell (2025), pp. 102873-102873
Closed Access
Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy
İsa Taş, Reinhilde Jacobs, Juliane Albrecht, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
İsa Taş, Reinhilde Jacobs, Juliane Albrecht, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Patient-Derived Explants as a Precision Medicine Patient-Proximal Testing Platform Informing Cancer Management
Abby R. Templeton, Penny L. Jeffery, Patrick B. Thomas, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 23
Abby R. Templeton, Penny L. Jeffery, Patrick B. Thomas, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 23
Artificial Intelligence-based Tumor Segmentation in Mouse Models of Lung Adenocarcinoma
Alena Arlova, Chengcheng Jin, Abigail Wong-Rolle, et al.
Journal of Pathology Informatics (2022) Vol. 13, pp. 100007-100007
Open Access | Times Cited: 13
Alena Arlova, Chengcheng Jin, Abigail Wong-Rolle, et al.
Journal of Pathology Informatics (2022) Vol. 13, pp. 100007-100007
Open Access | Times Cited: 13
Patient-derived tumoroids and proteomic signatures: tools for early drug discovery
Hélène Lê, Jules Deforges, Pasquale Cutolo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Hélène Lê, Jules Deforges, Pasquale Cutolo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Genomic evolution of non-small cell lung cancer patient-derived xenograft models
Robert E. Hynds, Ariana Huebner, David R. Pearce, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Robert E. Hynds, Ariana Huebner, David R. Pearce, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer
David R. Pearce, Ayse U. Akarca, Roel P. H. De Maeyer, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
David R. Pearce, Ayse U. Akarca, Roel P. H. De Maeyer, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
The somatic molecular evolution of cancer: Mutation, selection, and epistasis
Krishna Dasari, Jason A. Somarelli, Sudhir Kumar, et al.
Progress in Biophysics and Molecular Biology (2021) Vol. 165, pp. 56-65
Open Access | Times Cited: 14
Krishna Dasari, Jason A. Somarelli, Sudhir Kumar, et al.
Progress in Biophysics and Molecular Biology (2021) Vol. 165, pp. 56-65
Open Access | Times Cited: 14
Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro Cultures
Irena Wieleba, Kamila Wojas‐Krawczyk, Paweł Krawczyk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2261-2261
Open Access | Times Cited: 9
Irena Wieleba, Kamila Wojas‐Krawczyk, Paweł Krawczyk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2261-2261
Open Access | Times Cited: 9
Patient-Derived Lung Tumoroids—An Emerging Technology in Drug Development and Precision Medicine
Hélène Lê, Joseph Seitlinger, Véronique Lindner, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1677-1677
Open Access | Times Cited: 9
Hélène Lê, Joseph Seitlinger, Véronique Lindner, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1677-1677
Open Access | Times Cited: 9
The role of extracellular vesicles in non-small-cell lung cancer, the unknowns, and how new approach methodologies can support new knowledge generation in the field
S.F. Mullen, Dania Movia
European Journal of Pharmaceutical Sciences (2023) Vol. 188, pp. 106516-106516
Open Access | Times Cited: 5
S.F. Mullen, Dania Movia
European Journal of Pharmaceutical Sciences (2023) Vol. 188, pp. 106516-106516
Open Access | Times Cited: 5
Characterizing the secretome of EGFR mutant lung adenocarcinoma
Jennifer Luu, Fraser Johnson, Jana M. Jajarmi, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 1
Jennifer Luu, Fraser Johnson, Jana M. Jajarmi, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 1
Tenascin-C in the early lung cancer tumor microenvironment promotes progression through integrin activation and FAK
Shiela C. Samson, Anthony Rojas, Rebecca G. Zitnay, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Shiela C. Samson, Anthony Rojas, Rebecca G. Zitnay, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Free-flow zone electrophoresis facilitated proteomics analysis of heterogeneous subpopulations in H1299 lung cancer cells
Amir Sohail, Xiaoteng Jiang, Amir Wahid, et al.
Analytica Chimica Acta (2022) Vol. 1227, pp. 340306-340306
Closed Access | Times Cited: 7
Amir Sohail, Xiaoteng Jiang, Amir Wahid, et al.
Analytica Chimica Acta (2022) Vol. 1227, pp. 340306-340306
Closed Access | Times Cited: 7
Pten and p53 Loss in the Mouse Lung Causes Adenocarcinoma and Sarcomatoid Carcinoma
Sara Lázaro, Corina Lorz, Ana B. Enguita, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3671-3671
Open Access | Times Cited: 6
Sara Lázaro, Corina Lorz, Ana B. Enguita, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3671-3671
Open Access | Times Cited: 6